121735-02-2

Basic information

• Product Name: 4-isobutylbenzaMide
• Synonyms: 4-isobutylbenzaMide
• CAS NO: 121735-02-2
• Molecular Formula: C₁₁H₁₅NO
• Molecular Weight: 177.2429
• Mol File: 121735-02-2.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-isobutylbenzaMide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-isobutylbenzaMide(121735-02-2)
• EPA Substance Registry System: 4-isobutylbenzaMide(121735-02-2)

Safety Data

• Hazardous Substances Data: 121735-02-2(Hazardous Substances Data)

Upstream product

• 10342-60-6 1-isobutyl-4-nitrobenzene 

Downstream Products

• 1377582-27-8 4-Isobutyl-3-isothiocyanato-benzamide 
• 1377582-26-7 3-amino-4-isobutyl-benzamide 
• 1377582-28-9 4-isobutyl-3-thioureido-benzamide 

Relevant articles and documents

FUSED HETEROARYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION

This invention relates to thiazole I and its therapeutic and prophylactic uses, wherein the variables A, Q, J, R1, R3, and R5 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.

PYRIDYL-THIAZOLYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION

This invention relates to thiazole I and its therapeutic and prophylactic uses, wherein the variables Rz, Q, J, R1, R3, R5, and R6 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.

BISTHIAZOLE INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION

This invention relates to bisthiazole I and its therapeutic and prophylactic uses, wherein the variables A, R5, R6, and R7 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.

TRICYCLIC INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION

This invention relates to tricycle I and its therapeutic and prophylactic uses, wherein the variables C1, C2, Z1, Z2, Q, J, R1, and R3 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.

PHENYL-THIAZOLYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION

This invention relates to phenyl thiazole I and its therapeutic and prophylactic uses, wherein the variables Rz, Q, J, R1, R3, R5, R6, and R7 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.